COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,712 Articles (22,913 medRxiv, 8,799 bioRxiv)

Most recent first Previous |  Page 927: Articles 9261-9270  | Next

Seroneutralization of Omicron BA.1 and BA.2 in patients receiving anti-SARS-CoV-2 monoclonal antibodies.
Bruel, T., Hadjadj, J., Maes, P., Planas, D., Seve, A., Staropoli, I., Guivel-Benhassine, F., Porrot, F., Bolland, W.-H., Nguyen, Y., Casadevall, M., Charre, C., Pere, H., Veyer, D., Prot, M., Baidaliuk, A., Cuypers, L., Planchais, C., Mouquet, H., Baele, G., Mouthon, L., Hocqueloux, L., Simon-Loriere, E., Andre, E., Terrier, B., Prazuck, T., Schwartz, O.
10.1101/2022.03.09.22272066 — Posted: 2022-03-12
Blood group O and post-COVID-19 syndrome
Diaz-Salazar, S., Navas, R., Sainz-Maza, L., Fierro, P., Maamar, M., Artime, A., Basterrechea, H., Petitta, B., Lamadrid, C., Pedraja, L., Gandara-Samperio, C., Pini, S., Olmos, J. M., Ramos-Barron, C., Pariente, E., Hernandez, J. L.
10.1101/2022.03.10.22272197 — Posted: 2022-03-12
Evidence for SARS-CoV-2 Delta and Omicron co-infections and recombination
Bolze, A., White, S., Basler, T., Dei Rossi, A., Roychoudhury, P., Greninger, A. L., Hayashibara, K., Wyman, D., Kil, E., Dai, H., Cassens, T., Tsan, K., Nguyen, J., Ramirez, J., Carter, S., Cirulli, E. T., Schiabor Barrett, K., Belda-Ferre, P., Washington, N. L., Jacobs, S., Sandoval, E., Becker, D., Lu, J. T., Isaksson, M., Lee, W., Luo, S.
10.1101/2022.03.09.22272113 — Posted: 2022-03-12
Prevention of SARS-CoV-2 airborne transmission in a workplace based on CO2 sensor network
Yokogawa, S., Ishigaki, Y., Kitamura, H., Saito, A., Kawauchi, Y.
10.1101/2022.03.04.22271934 — Posted: 2022-03-12
Different Covid-19 Outcomes Among Systemic Rheumatic Diseases: A Nation-wide Cohort Study
Bournia, V.-K., Fragoulis, G., Mitrou, P., Mathioudakis, K., Tsolakidis, A., Konstantonis, G., Tseti, I., Vourli, G., Tektonidou, M. G., Paraskevis, D., Sfikakis, P. P.
10.1101/2022.03.11.22271887 — Posted: 2022-03-12
Pharmacokinetics of favipiravir in adults with mild COVID-19 in Thailand
Manosuthi, W., Prasanchaimontri, I.-o., Niyomnaitham, S., Sirijatuphat, R., Charoenpong, L., Copeland, K., Cressey, T. R., Mokmued, P., Chokephaibulkit, K.
10.1101/2022.03.09.22271220 — Posted: 2022-03-12
Alveolar regeneration following viral infection is independent of tuft cells
Que, J., Huang, H., Jiang, M., Zhang, Y., Biermann, J., Melms, J. C., Danielsson, J., Fang, Y., Yang, Y., Qiang, L., Liu, J., Zhou, Y., Wang, M., Hu, Z., Wang, T., Saqi, A., Sun, J., Matsumoto, I., Cardoso, W. V., Emala, C., Zhu, J., Izar, B., Mou, H.
10.1101/2022.03.11.483948 — Posted: 2022-03-12
Crystal structures and fragment screening of SARS-CoV-2 NSP14 reveal details of exoribonuclease activation and mRNA capping and provide starting points for antiviral drug development
Imprachim, N., Yosaatmadja, Y., Newman, J.
10.1101/2022.03.11.483836 — Posted: 2022-03-12
Innate immune response and distinct metabolomic signatures together drive and shape the SARS-CoV-2-specific T cell response during COVID-19
Binayke, A., Zaheer, A., Dandotiya, J., Gupta, S. K., Mani, S., Tripathy, M. R., Madan, U., Shrivastava, T., Kumar, Y., Pandey, A. K., Rathore, D. K., Awasthi, A.
10.1101/2022.03.11.483930 — Posted: 2022-03-12
Immunogenicity and safety of a recombinant adenovirus type-5 COVID 19 vaccine in adults: data from a randomised, double-blind, placebo-controlled, single-dose, phase 3 trial in Russia
Dzutseva, V., Lioznov, D., Amosova, I., Sheetikov, S. A., Zornikova, K. V., Serdyuk, Y., Efimov, G. A., Tsyferov, M., Khmelevskii, M., Afansiev, A., Khomyakova, N., Zubkov, D., Tikhonov, A., Zhu, T., Barreto, L.
10.1101/2022.03.01.22271507 — Posted: 2022-03-11

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).